Evogene to Present at the 26th Asian-Pacific Weed Science Society Conference
August 23 2017 - 7:00AM
Evogene Ltd., (NASDAQ:EVGN) (TASE:EVGN), a leading company for the
improvement of crop productivity, announced today that the R&D
director of its Ag-Chemicals activity area, Dr. Boaz Inbal, will
present the company’s biology-driven computational chemistry
platform, including proprietary Artificial Intelligence predictive
models, and novel product pipeline.
Dr. Inbal will be presenting at the Asian
Pacific Weed Science Society Conference taking place September
19th-22nd, 2017 in Kyoto, Japan. Dr. Inbal’s presentation is
scheduled for September 20th (Wed) at 14:30.
In his presentation, Dr. Inbal will describe
Evogene’s unique approach for biology-driven discovery and
optimization of novel pesticides, addressing market challenges of
increasing resistance and product safety. Evogene’s computational
platform is utilized in the collaboration with BASF, as well as in
internal programs and other collaborations.
South East Asian markets are important
Agriculture growth markets, as they consist of more than a third of
the world’s population. Evogene's unique approach complements the
growing need for Ag-Innovation in these markets.
About Evogene Ltd.:Evogene
(NASDAQ:EVGN) (TASE:EVGN) is a leading biotechnology company for
the improvement of crop productivity for the food, feed and fuel
industries. The Company operates in three key target markets:
improved seed traits (addressing yield increase, tolerance to
environmental stresses and resistance to insects and diseases);
innovative ag-chemicals (developing novel herbicide solutions for
weed control); and ag-biologicals. Evogene has collaborations with
world-leading seed and ag-chemical companies. For more information,
please visit www.evogene.com or contact the Company at
info@evogene.com.
Forward Looking Statements:This
press release contains “forward-looking statements” relating to
future events. These statements may be identified by words such as
“may”, “could”, “expects”, "intends", “anticipates”, “plans”,
“believes”, “scheduled”, “estimates” or words of similar meaning.
Such statements are based on current expectations, estimates,
projections and assumptions, describe opinions about future events,
involve certain risks and uncertainties which are difficult to
predict and are not guarantees of future performance. Therefore,
actual future results, performance or achievements of Evogene may
differ materially from what is expressed or implied by such
forward-looking statements due to a variety of factors, many of
which beyond Evogene's control, including, without limitation,
those risk factors contained in Evogene’s reports filed with the
appropriate securities authority. Evogene disclaims any obligation
or commitment to update these forward-looking statements to reflect
future events or developments or changes in expectations,
estimates, projections and assumptions.
Contact:
Nir Zalik
IR/PR Manager
E: IR@evogene.com
T: (+972)-8-931-1963
Evogene (NASDAQ:EVGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Evogene (NASDAQ:EVGN)
Historical Stock Chart
From Sep 2023 to Sep 2024